PneuMotion

Respiratory monitoring for the detection of opioid induced respiratory depression

About PneuMotion

Adverse opioid events can cause significant injury or death and are associated with greater hospital costs. Reducing or eliminating these events requires continuous respiratory monitoring. PneuMotion provides continuous respiratory rate monitoring and obstructive apnea detection. PneuMotion seamlessly integrates into a hospital's existing network and allows mobile respiratory monitoring and EHR data collection. Ultra-low cost sensor technology makes this a cost-effective solution for opioid safety.

27 Million

Patients receiving opioid pain medications each year

$7 Billion

Healthcare costs related to respiratory insufficiency, arrest

$4 Million

Average malpractice settlement involving sleep apnea and adverse opioid events

Hospital Respiratory Monitoring

Home Overdose Monitoring

award
award

MedTech Innovator's top 100 companies for 2017

Meet our team

Ken

Ken Bernstein

Founder and CEO

Bryce

Bryce Hill

Founder and CTO

Ric

Ric Telford

Founder and COO

New

Bret Askeland

Software Development

Contact Us